Svb Wealth LLC Biotechnology

Svb Wealth LLC

$2.41 Billion
Q1 2025

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
VRTX Vertex Pharmaceuticals Inc	$113B	$5.16 Million 0.21% of portfolio	10,636	Q1 2025 Reduced 29.86%
TECH Bio Techne Corp	$1.96B	$2.49 Million 0.1% of portfolio	42,403	Q1 2025 Added 85.52%
REGN Regeneron Pharmaceuticals, Inc.	$54.6B	$396,000 0.02% of portfolio	625	Q1 2025 Reduced 37.0%
SMMT Summit Therapeutics Inc.	$4.08B	$236,000 0.01% of portfolio	12,250	Q1 2025 Reduced 20.2%
BNTX Bio N Tech Se	$25.9B	$162,000 0.01% of portfolio	1,783	Q1 2025 Reduced 0.28%
ARGX Argenx Se	$30B	$94,000 0.0% of portfolio	160	Q1 2025 New
RPRX Royalty Pharma PLC	$15.2B	$90,000 0.0% of portfolio	2,917	Q1 2025 New
INCY Incyte Corp	$15.2B	$39,000 0.0% of portfolio	648	Q1 2025 New
TGTX Tg Therapeutics, Inc.	$5.23B	$37,000 0.0% of portfolio	951	Q1 2025 New
JAZZ Jazz Pharmaceuticals PLC	$6.74B	$36,000 0.0% of portfolio	290	Q1 2025 New
ADMA Adma Biologics, Inc.	$3.53B	$35,000 0.0% of portfolio	1,775	Q1 2025 New
HALO Halozyme Therapeutics, Inc.	$7.36B	$32,000 0.0% of portfolio	510	Q1 2025 New
UTHR United Therapeutics Corp	$13.2B	$32,000 0.0% of portfolio	105	Q1 2025 New
MRNA Moderna, Inc.	$10.1B	$28,000 0.0% of portfolio	1,004	Q1 2025 New
ALNY Alnylam Pharmaceuticals, Inc.	$38.1B	$27,000 0.0% of portfolio	100	Q1 2025 New
CRSP Crispr Therapeutics Ag	$3.45B	$24,000 0.0% of portfolio	730	Q1 2025 New
VCEL Vericel Corp	$1.98B	$20,000 0.0% of portfolio	461	Q1 2025 New
VKTX Viking Therapeutics, Inc.	$1.99B	$17,000 0.0% of portfolio	725	Q1 2025 New
BMRN Biomarin Pharmaceutical Inc	$10.2B	$13,000 0.0% of portfolio	186	Q1 2025 New
CYTK Cytokinetics Inc	$3.05B	$12,000 0.0% of portfolio	323	Q1 2025 New
PTGX Protagonist Therapeutics, Inc	$2.61B	$12,000 0.0% of portfolio	261	Q1 2025 New
EXEL Exelixis, Inc.	$13B	$11,000 0.0% of portfolio	303	Q1 2025 New
MRUS Merus N.V.	$2.44B	$9,000 0.0% of portfolio	223	Q1 2025 New
ARWR Arrowhead Pharmaceuticals, Inc.	$1.62B	$6,000 0.0% of portfolio	473	Q1 2025 New
BPMC Blueprint Medicines Corp	$7.66B	$6,000 0.0% of portfolio	77	Q1 2025 New
PTCT Ptc Therapeutics, Inc.	$3.59B	$6,000 0.0% of portfolio	130	Q1 2025 New
ABUS Arbutus Biopharma Corp	$517M	$5,000 0.0% of portfolio	1,719	Q1 2025 New
RNA Avidity Biosciences, Inc.	$1.53B	$5,000 0.0% of portfolio	189	Q1 2025 New
CPRX Catalyst Pharmaceuticals, Inc.	$2.31B	$5,000 0.0% of portfolio	231	Q1 2025 New
IBRX Immunity Bio, Inc.	$1.15B	$5,000 0.0% of portfolio	1,780	Q1 2025 New
LEGN Legend Biotech Corp	$5.69B	$5,000 0.0% of portfolio	154	Q1 2025 New
RARE Ultragenyx Pharmaceutical Inc.	$2.6B	$5,000 0.0% of portfolio	139	Q1 2025 New
ARQT Arcutis Biotherapeutics, Inc.	$832M	$4,000 0.0% of portfolio	262	Q1 2025 New
BBIO Bridge Bio Pharma, Inc.	$6.19B	$4,000 0.0% of portfolio	125	Q1 2025 New
NAUT Nautilus Biotechnology, Inc.	$91M	$4,000 0.0% of portfolio	5,094	Q1 2025 New
AVXL Anavex Life Sciences Corp.	$709M	$3,000 0.0% of portfolio	382	Q1 2025 New
BEAM Beam Therapeutics Inc.	$1.18B	$3,000 0.0% of portfolio	176	Q1 2025 New
COGT Cogent Biosciences, Inc.	$472M	$3,000 0.0% of portfolio	539	Q1 2025 New
PRTA Prothena Corp Public LTD CO	$268M	$3,000 0.0% of portfolio	274	Q1 2025 New
REPL Replimune Group, Inc.	$457M	$3,000 0.0% of portfolio	391	Q1 2025 New
QURE Uni Qure N.V.	$664M	$3,000 0.0% of portfolio	350	Q1 2025 New
ACAD Acadia Pharmaceuticals Inc	$3.68B	$2,000 0.0% of portfolio	166	Q1 2025 New
APLS Apellis Pharmaceuticals, Inc.	$1.94B	$2,000 0.0% of portfolio	94	Q1 2025 New
ASND Ascendis Pharma A/S	$9.87B	$2,000 0.0% of portfolio	18	Q1 2025 New
BGNE Bei Gene, Ltd.	$23.5B	$2,000 0.0% of portfolio	12	Q1 2025 New
DYN Dyne Therapeutics, Inc.	$540M	$2,000 0.0% of portfolio	250	Q1 2025 New
LGND Ligand Pharmaceuticals Inc	$1.93B	$2,000 0.0% of portfolio	23	Q1 2025 New
RVMD Revolution Medicines, Inc.	$3.48B	$2,000 0.0% of portfolio	65	Q1 2025 New
ROIV Roivant Sciences Ltd.	$8.07B	$2,000 0.0% of portfolio	218	Q1 2025 New
SRRK Scholar Rock Holding Corp	$1.76B	$2,000 0.0% of portfolio	74	Q1 2025 New

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Svb Wealth LLC, based on Form 13F filings with the SEC.

News

Stay updated on Svb Wealth LLC with notifications on news.